Literature DB >> 27335459

HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins.

Kasia Hrecka1, Caili Hao1, Ming-Chieh Shun1, Sarabpreet Kaur1, Selene K Swanson2, Laurence Florens2, Michael P Washburn3, Jacek Skowronski4.   

Abstract

HIV replication in nondividing host cells occurs in the presence of high concentrations of noncanonical dUTP, apolipoprotein B mRNA-editing, enzyme-catalytic, polypeptide-like 3 (APOBEC3) cytidine deaminases, and SAMHD1 (a cell cycle-regulated dNTP triphosphohydrolase) dNTPase, which maintains low concentrations of canonical dNTPs in these cells. These conditions favor the introduction of marks of DNA damage into viral cDNA, and thereby prime it for processing by DNA repair enzymes. Accessory protein Vpr, found in all primate lentiviruses, and its HIV-2/simian immunodeficiency virus (SIV) SIVsm paralogue Vpx, hijack the CRL4(DCAF1) E3 ubiquitin ligase to alleviate some of these conditions, but the extent of their interactions with DNA repair proteins has not been thoroughly characterized. Here, we identify HLTF, a postreplication DNA repair helicase, as a common target of HIV-1/SIVcpz Vpr proteins. We show that HIV-1 Vpr reprograms CRL4(DCAF1) E3 to direct HLTF for proteasome-dependent degradation independent from previously reported Vpr interactions with base excision repair enzyme uracil DNA glycosylase (UNG2) and crossover junction endonuclease MUS81, which Vpr also directs for degradation via CRL4(DCAF1) E3. Thus, separate functions of HIV-1 Vpr usurp CRL4(DCAF1) E3 to remove key enzymes in three DNA repair pathways. In contrast, we find that HIV-2 Vpr is unable to efficiently program HLTF or UNG2 for degradation. Our findings reveal complex interactions between HIV-1 and the DNA repair machinery, suggesting that DNA repair plays important roles in the HIV-1 life cycle. The divergent interactions of HIV-1 and HIV-2 with DNA repair enzymes and SAMHD1 imply that these viruses use different strategies to guard their genomes and facilitate their replication in the host.

Entities:  

Keywords:  HIV; SAMHD1; Vpr; postreplication DNA repair; restriction

Mesh:

Substances:

Year:  2016        PMID: 27335459      PMCID: PMC4941427          DOI: 10.1073/pnas.1605023113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  71 in total

1.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

2.  Abundant non-canonical dUTP found in primary human macrophages drives its frequent incorporation by HIV-1 reverse transcriptase.

Authors:  Edward M Kennedy; Waaqo Daddacha; Rebecca Slater; Christina Gavegnano; Emilie Fromentin; Raymond F Schinazi; Baek Kim
Journal:  J Biol Chem       Date:  2011-03-31       Impact factor: 5.157

Review 3.  Base excision repair.

Authors:  Hans E Krokan; Magnar Bjørås
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-04-01       Impact factor: 10.005

4.  Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. II. Evidence for a strand displacement mechanism in plus-strand synthesis.

Authors:  L R Boone; A M Skalka
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

5.  Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques.

Authors:  Yoshiaki Nishimura; Charles R Brown; Joseph J Mattapallil; Tatsuhiko Igarashi; Alicia Buckler-White; Bernard A P Lafont; Vanessa M Hirsch; Mario Roederer; Malcolm A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

6.  SHPRH and HLTF act in a damage-specific manner to coordinate different forms of postreplication repair and prevent mutagenesis.

Authors:  Jia-Ren Lin; Michelle K Zeman; Jia-Yun Chen; Muh-Ching Yee; Karlene A Cimprich
Journal:  Mol Cell       Date:  2011-03-10       Impact factor: 17.970

Review 7.  Causes and consequences of replication stress.

Authors:  Michelle K Zeman; Karlene A Cimprich
Journal:  Nat Cell Biol       Date:  2014-01       Impact factor: 28.824

8.  Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme.

Authors:  M Bouhamdan; S Benichou; F Rey; J M Navarro; I Agostini; B Spire; J Camonis; G Slupphaug; R Vigne; R Benarous; J Sire
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  Differential association of uracil DNA glycosylase with SIVSM Vpr and Vpx proteins.

Authors:  R Sleigh; M Sharkey; M A Newman; B Hahn; M Stevenson
Journal:  Virology       Date:  1998-06-05       Impact factor: 3.513

10.  Vpr expression abolishes the capacity of HIV-1 infected cells to repair uracilated DNA.

Authors:  Patrick Eldin; Nathalie Chazal; David Fenard; Eric Bernard; Jean-François Guichou; Laurence Briant
Journal:  Nucleic Acids Res       Date:  2013-10-30       Impact factor: 16.971

View more
  39 in total

1.  Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.

Authors:  Caitlin M Miller; Hisashi Akiyama; Luis M Agosto; Ann Emery; Chelsea R Ettinger; Ronald I Swanstrom; Andrew J Henderson; Suryaram Gummuluru
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  G-quadruplex ligands targeting telomeres do not inhibit HIV promoter activity and cooperate with latency reversing agents in killing latently infected cells.

Authors:  Dorota Piekna-Przybylska; Robert A Bambara; Sanjay B Maggirwar; Stephen Dewhurst
Journal:  Cell Cycle       Date:  2020-08-17       Impact factor: 4.534

3.  HIV-1 Vif's Capacity To Manipulate the Cell Cycle Is Species Specific.

Authors:  Edward L Evans; Jordan T Becker; Stephanie L Fricke; Kishan Patel; Nathan M Sherer
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

4.  Quantitative Temporal Viromics of an Inducible HIV-1 Model Yields Insight to Global Host Targets and Phospho-Dynamics Associated with Protein Vpr.

Authors:  John D Lapek; Mary K Lewinski; Jacob M Wozniak; John Guatelli; David J Gonzalez
Journal:  Mol Cell Proteomics       Date:  2017-06-12       Impact factor: 5.911

5.  The DDB1-DCAF1-Vpr-UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction.

Authors:  Ying Wu; Xiaohong Zhou; Christopher O Barnes; Maria DeLucia; Aina E Cohen; Angela M Gronenborn; Jinwoo Ahn; Guillermo Calero
Journal:  Nat Struct Mol Biol       Date:  2016-08-29       Impact factor: 15.369

6.  HIV-1 Vpr hijacks EDD-DYRK2-DDB1DCAF1 to disrupt centrosome homeostasis.

Authors:  Delowar Hossain; Jérémy A Ferreira Barbosa; Éric A Cohen; William Y Tsang
Journal:  J Biol Chem       Date:  2018-05-03       Impact factor: 5.157

7.  Vpu modulates DNA repair to suppress innate sensing and hyper-integration of HIV-1.

Authors:  Lisa Wiesmüller; Frank Kirchhoff; Meta Volcic; Konstantin M J Sparrer; Lennart Koepke; Dominik Hotter; Daniel Sauter; Christina M Stürzel; Myriam Scherer; Thomas Stamminger; Thomas G Hofmann; Nathalie J Arhel
Journal:  Nat Microbiol       Date:  2020-07-20       Impact factor: 17.745

8.  HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity.

Authors:  Kelly M Marno; Rebecca Pike; Joseph M Gibbons; Wing-Yiu Jason Lee; Christopher E Jones; Babatunji W Ogunkolade; Claire Pardieu; Alexander Bryan; Rebecca Menhua Fu; Gary Warnes; Paul A Rowley; Richard D Sloan; Áine McKnight
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

9.  Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly.

Authors:  Hong Wang; Haoran Guo; Jiaming Su; Yajuan Rui; Wenwen Zheng; Wenying Gao; Wenyan Zhang; Zhaolong Li; Guanchen Liu; Richard B Markham; Wei Wei; Xiao-Fang Yu
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

Review 10.  The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Brian J North; Kaixiong Tao; Pengbo Zhou; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-12-30       Impact factor: 10.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.